User profiles for ANTONIO SPADARO

Antonio Spadaro

Sapienza University of Rome
Verified email at uniroma1.it
Cited by 4625

[BOOK][B] Cybertheology: thinking Christianity in the era of the Internet

A Spadaro, M Way - 2014 - brill.com
Antonio Spadaro is the editor of the review La Civilią Cattolica and teacher at the Pontifical
Gregorian University. His book Cybertheology is a study that evaluates how technology is …

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study

…, A Marchesoni, WJ Taylor, A Spadaro… - The Journal of …, 2011 - jrheum.org
Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …

Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.

A Spadaro, V Riccieri, A Sili-Scavalli… - Clinical and …, 1995 - europepmc.org
Objective To compare the effectiveness and toxicity of cyclosporin A (CsA) vs low-dose
methotrexate (MTX) over a period of one year in the treatment of psoriatic arthritis (PsA) with …

Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia

A Marchesoni, F Atzeni, A Spadaro, E Lubrano… - The Journal of …, 2012 - jrheum.org
Objective. To identify the clinical features that can help to distinguish between psoriatic
arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 …

Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis

A Spadaro, A Iagnocco, FM Perrotta, M Modesti… - …, 2011 - academic.oup.com
Objective. The aim of this study was to compare clinical examination with power Doppler US
(PDUS) in the detection of entheseal abnormalities in patients with AS. Methods. Thirty-six …

Switching tumour necrosis factor α antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period

…, L Magrini, FR Spinelli, A Spadaro… - Annals of the …, 2007 - ard.bmj.com
Objective: To evaluate the clinical response after switching from one tumour necrosis factor (TNF)α
antagonist to another in patients with ankylosing spondylitis (AS) and psoriatic …

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study

A Spadaro, E Lubrano, A Marchesoni… - …, 2013 - academic.oup.com
Objective. The primary objective of this retrospective study was to investigate the possibility
of achieving partial remission (PR) in AS patients treated with anti-TNF-α antagonists, such …

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients

L Costa, F Caso, M Atteno, C Giannitti, A Spadaro… - Clinical …, 2014 - Springer
Psoriatic arthritis (PsA) is an inflammatory arthropathy associated with skin and/or nail
psoriasis. TNF-α, in addition to its pro-inflammatory role, is an essential cytokine for the host's …

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to …

…, C Salvarani, A Cauli, E Lubrano, A Spadaro… - …, 2008 - academic.oup.com
Objective. To evaluate costs, benefits and cost–effectiveness of anti-TNF agents in PsA
patients with inadequate response to conventional treatment. Methods. A total of 107 patients, …

Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis

…, I Olivieri, S D'ANGELO, A Spadaro… - The Journal of …, 2009 - jrheum.org
Objective. To develop and validate a modified index for assessing the radiologic axial
involvement in psoriatic arthritis (PsA) in a group of patients with established disease. Methods. …